Pure Global AI
Manufacturer profile

TECHNOCLONE HERSTELLUNG VON DIAGNOSTIKA UND ARZNEIMITTEL GMBH

BrazilAustria14 ANVISA registrations8 unique technical categoriesJan 09, 2023 – Jun 15, 2026
Verified
14
Total products
8
Technical names
Jan 2023
Earliest registration
Jun 2026
Latest registration
Regulatory footprint
Search TECHNOCLONE HERSTELLUNG VON DIAGNOSTIKA UND ARZNEIMITTEL GMBH across other regulatory registries
ThailandEuropean UnionVietnamSouth KoreaEcuadorUnited States
Recent registrations
Latest 5 products registered by this manufacturer
COAGULATION FACTOR VIII
Technochrom FVIII:C 2G CAL
Class II · Jun 15, 2026
COAGULATION FACTOR VIII
Technochrom FVIII:C 2G
Class II · Jun 15, 2026
TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL
Technochrom Dilution Buffer
Class I · Jun 15, 2026
COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II
5800102TECHNOFLUOR ADAMTS13 Activity 0 CAL
Class II · Mar 06, 2023
THROMBIN TIME (TT)
FAMILIA CEVERON TGA GERAÇÃO TROMBINA
Class II · Mar 06, 2023
Most popular products
Products with most registrations
ADAMTS 13 (VON WILLEBRAND FACTOR CLEAVING PROTEASE)
5 registrations
COAGULATION FACTOR VIII
2 registrations
COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II
2 registrations
TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL
1 registrations
THROMBIN TIME (TT)
1 registrations
Top registration holders
Companies holding product registrations for this manufacturer
ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDA
14 products
Top competitors
Companies with the most overlapping products (same technical names)
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Germany
43 registrations7 shared products
Shared products
COAGULATION FACTOR VIII, COAGULATION FACTOR XIII, COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II, Instrument for hemostasis, PRODUCT FOR HEMOSTASIS ASSESSMENT, TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL, THROMBIN TIME (TT)
DIAGNOSTICA STAGO S.A.S
France
20 registrations7 shared products
Shared products
COAGULATION FACTOR VIII, COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II, Instrument for hemostasis, PRODUCT FOR HEMOSTASIS ASSESSMENT, PRODUTO PARA AVALIAÇÃO DA HEMOSTASIA, TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL, THROMBIN TIME (TT)
ROCHE DIAGNOSTICS GMBH
Germany
96 registrations6 shared products
Shared products
COAGULATION FACTOR VIII, COAGULATION FACTOR XIII, COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II, Instrument for hemostasis, TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL, THROMBIN TIME (TT)
INSTRUMENTATION LABORATORY CO.
United States
11 registrations5 shared products
Shared products
ADAMTS 13 (VON WILLEBRAND FACTOR CLEAVING PROTEASE), COMBINED PARAMETERS IN THE SAME PRODUCT - CLASS II, Instrument for hemostasis, TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL, THROMBIN TIME (TT)
TCOAG IRELAND LIMITED
Ireland
9 registrations5 shared products
Shared products
COAGULATION FACTOR VIII, Instrument for hemostasis, PRODUCT FOR HEMOSTASIS ASSESSMENT, TAMPÕES, DILUENTES E DEMAIS SOLUÇÕES PARA ANÁLISE LABORATORIAL, THROMBIN TIME (TT)
About this profile

Explore comprehensive manufacturer profile for TECHNOCLONE HERSTELLUNG VON DIAGNOSTIKA UND ARZNEIMITTEL GMBH based in Austria through Pure Global AI's free Brazil medical device database. This manufacturer has 14 products registered with ANVISA across 8 unique technical categories. Their regulatory history spans from Jan 09, 2023 to Jun 15, 2026.

This page provides detailed insights including 5 recent product registrations including COAGULATION FACTOR VIII, 5 most popular products with ADAMTS 13 (VON WILLEBRAND FACTOR CLEAVING PROTEASE) having 5 registrations, 1 registration holders including ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDA, and 5 key competitors with SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH sharing 7 products. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, enabling global MedTech companies to analyze market dynamics and identify opportunities.